2016
Duncan, D., T. Kamerzell and M. Palmer. 2016. Use of Indole Compounds for Fat Reduction and Skin and Soft Tissue Tightening. Patent Applications US 20160030389 A1.
2014
Iizuka, K., T. Machida, and M. Hirafuji. 2014. Extracellular MCT4 Is a Possible Indicator for Skeletal Muscle MHC Fiber Type Change. Ann Clin Lab Sci, 44:272-276.
2013
Wang, G., and Q. Lu. 2013. A nitrate ester of sedative alkyl alcohol improves muscle function and structure in a murine model of Duchenne muscular dystrophy. Molecular pharmaceutics. 10:3862-3870.
2012
Idris, N., M. Ashraf, R. Ahmed, J. Shujia, and K. Haider. 2012. Activation of IL-11/STAT3 pathway in preconditioned human skeletal myoblasts blocks apoptotic cascade under oxidant stress. Regen Med, 7:47-57.
Nagao, H., T. Setoguchi, S. Kitamoto, Y. Ishidou, S. Nagano, M. Yokouchi, M. Abematsu, N. Kawabata, S. Maeda, S. Yonezawa, and S. Komiya. 2012. RBPJ Is a Novel Target for Rhabdomyosarcoma Therapy. PloS one. 7:e39268.
Wang, M., J.D. Tucker, P. Lu, B. Wu, C. Cloer, and Q. Lu. 2012. Tris[2-(acryloyloxy)ethyl]isocyanurate Cross-Linked Low-Molecular-Weight Polyethylenimine as Gene Delivery Carriers in Cell Culture and Dystrophic mdx Mice. Bioconjugate chemistry. 23:837-845.
2011
Kawabata, N., K. Ijiri, Y. Ishidou, T. Yamamoto, H. Nagao, S. Nagano, S. Maeda, S. Komiya, and T. Setoguchi. 2011. Pharmacological inhibition of the Hedgehog pathway prevents human rhabdomyosarcoma cell growth. International journal of oncology. 39:899.
Kunigou, O., H. Nagao, N. Kawabata, Y. Ishidou, S. Nagano, S. Maeda, S. Komiya, and T. Setoguchi. 2011. Role of GOLPH3 and GOLPH3L in the proliferation of human rhabdomyosarcoma. Oncology reports. 26:1337-1342.
2010
Thuangtong, R., J.J. Bentow, K. Knopp, N.A. Mahmood, N.E. David, and M.S. Kolodney. 2010. Tissue‐Selective Effects of Injected Deoxycholate. Dermatologic Surgery. 36:899-908.
Zalevsky, J., D. Nguyen, G. Moore, S. Ezhevsky, J. Desjarlais, A. Chirino, D. Cash, and M. Bernett. 2010. Pharmaceutical compositions of adiponectin variants and methods of storage. Patent US 7678886 B2.
Zalevsky, J., D. Nguyen, G. Moore, S. Ezhevsky, J. Desjarlais, A. Chirino, D. Cash, and M. Bernett. 2010. Adiponectin variants. Patent US 7709607 B2.
Zalevsky, J., D. Nguyen, G. Moore, S. Ezhevsky, J. Desjarlais, A. Chirino, D. Cash, and M. Bernett. 2010. Method of treatment using adiponectin variants. Patent US 7749956 B2.
2009
Gupta, A., C. Lobocki, S. Singh, M. Robertson, O.A. Akadiri, G. Malhotra, and I.T. Jackson. 2009. Actions and Comparative Efficacy of Phosphatidylcholine Formulation and Isolated Sodium Deoxycholate for Different Cell Types. Aesth Plast Surg. 33:346-352.
Hirotsu, M., T. Setoguchi, Y. Matsunoshita, H. Sasaki, H. Nagao, H. Gao, K. Sugimura, and S. Komiya. 2009. Tumour formation by single fibroblast growth factor receptor 3-positive rhabdomyosarcoma-initiating cells. Br J Cancer. 101:2030-2037.
Peters, L., and T. Lorenz. 2009. Postsynaptically Targeted Chemodenervation Agents and Their Methods of Use. Patent Application US 20110118190 A1.
Xu, J., S. Ekins, M. McGlashen, and D. Lauffenburger. 2009. FUTURE PERSPECTIVES OF BIOLOGICAL ENGINEERING IN PHARMACEUTICAL RESEARCH: THE PARADIGM OF MODELING, MINING, MANIPULATION, AND MEASUREMENTS. Ch. 14 inXu, J. and Ekins, S. 2009. Drug Efficacy, Safety, and Biologics Discovery: Emerging Technologies and Tools.
Xu, J. and L. Yu. 2009. Focus on the Fundamentals: Toward Better Therapeutic Index Prediction. Pg 19. In: Drug Efficacy, Safety, and Biologics Discovery: Emerging Technologies and Tools. Ekins S. and X Jinghai, Eds. John Wiley & Sons, Inc.
Zalevsky, J., D. Nguyen, G. Moore, S. Ezhevsky, J. Desjarlais, A. Chirino, D. Cash, and M. Bernett. 2009. Globular adiponectin variants. Patent US 7592423 B2.
2008
Wang, Y.-J., M.-W. Lin, A.-A. Lin, and S.-N. Wu. 2008. Riluzole-induced block of voltage-gated Na+ current and activation of BKCa channels in cultured differentiated human skeletal muscle cells. Life sciences. 82:11-20.
2006
Cash, D., A. Chirino, J. Desjarlais, S. Ezhevsky, G. Moore, D. Nguyen, and J. Zalevsky. 2006. Adiponectin variants. Patent Application US 20070015909 A1.
Perla, V., and T.J. Webster. 2006. nano-hydroxyapatite–thermally denatured small intestine sub-mucosa composites for entheses applications. International Journal of nanomedicine. 1:351.
Yamazaki, H., M. Suzuki, T. Aoki, S. Morikawa, T. Maejima, F. Sato, K. Sawanobori, M. Kitahara, T. Kodama, and Y. Saito. 2006. Influence of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on ubiquinone levels in rat skeletal muscle and heart: relationship to cytotoxicity and inhibitory activity for cholesterol synthesis in human skeletal muscle cells. Journal of atherosclerosis and thrombosis. 13:295-307.
Zalevsky, J., D. Nguyen, G. Moore, S. Ezhevsky, J. Desjarlais, A. Chirino, D. Cash, and M. Bernett. 2006. Rational Chemical Modification of Adiponectin Variants. Patent Application US 20070054359 A1.
2005
Morikawa, S., T. Murakami, H. Yamazaki, A. Izumi, Y. Saito, T. Hamakubo, and T. Kodama. 2005. Analysis of the global RNA expression profiles of skeletal muscle cells treated with statins. J. atherosclerosis & thrombosis. 12:121-131.
Patton, J.R., Y. Bykhovskaya, E. Mengesha, C. Bertolotto, and N. Fischel-Ghodsian. 2005. Mitochondrial Myopathy and Sideroblastic Anemia (MLASA): Missense mutation in the pseudouridine synthase 1 (PUS1) gene is associated with the loss of tRNA pseudouridylation. J. Biological Chemistry. 280:19823-19828.
Perla, V., M. Sato, and T.J. Webster. 2005. Increased Skeletal Muscle Cell and Osteoblast Numbers on Hydrothermally-Treated Nano-Hydroxyapatite/Collagen Type I Composites for Entheses Applications. Journal of Biomedical Nanotechnology. 1:297-305.
2004
Yamamoto, J., Y. Ikeda, H. Iguchi, T. Fujino, T. Tanaka, H. Asaba, S. Iwasaki, R.X. Ioka, I.W. Kaneko, K. Magoori, S. Takahashi, T. Mori, H. Sakaue, T. Kodama, M. Yanagisawa, T.T. Yamamoto, S. Ito, and J. Sakai. 2004. A Krüppel-like factor KLF15 Contributes Fasting-induced Transcriptional Activation of Mitochondrial Acetyl-CoA Synthetase Gene AceCS2. Journal of Biological Chemistry. 279:16954-16962.
